The cases emphasize the necessity of early appropriate screening of LADA to avoid misclassification, including of patients who do not fit the typical T2D profile or who present unexpected clinical courses such as poor glycemic control or becoming insulin-dependent sooner than expected [10]. The gene discussed is INS; the disease is type 2 diabetes mellitus.